Clinical Trial Update: Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether angiotensin receptor blockers affect progression to acute respiratory distress syndrome in SARS-CoV infection; complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov Infection

Snippet

Sponsor: Sharp HealthCare | Conditions: SARS-CoV Infection | Phase 4 | Status: COMPLETED | Results posted: 2021-05-26